Patricia Carr insider trades: Jazz Pharmaceuticals (JAZZ) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Patricia reports to the SEC
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | JAZZ | ↓ Sell | 1,413 | $231.36 | $327K | Direct | Nov 6, 2026 (2d) |
| Mar 9, 2026 | JAZZ | ↓ Sell | 1,287 | $182.94 | $235K | Direct | Mar 9, 2026 (0d) |
| Feb 27, 2026 | JAZZ | ↓ Sell | 2,370 | $192.60 | $456K | Direct | Mar 2, 2026 (3d) |
| Dec 5, 2025 | JAZZ | ↓ Sell | 4,660 | $171.20 | $798K | Direct | Dec 9, 2025 (4d) |
| Nov 18, 2025 | JAZZ | ↓ Sell | 5,319 | $182.06 | $968K | Direct | Nov 20, 2025 (2d) |
| Mar 10, 2025 | JAZZ | ↓ Sell | 1,140 | $137.81 | $157K | Direct | Mar 11, 2025 (1d) |
| Feb 28, 2025 | JAZZ | ↓ Sell | 5,586 | $144.26 | $806K | Direct | Mar 3, 2025 (3d) |
| Dec 2, 2024 | JAZZ | ↓ Sell | 53 | $122.49 | $6K | Direct | Dec 4, 2024 (2d) |
| Jun 7, 2024 | JAZZ | ↓ Sell | 163 | $108.83 | $18K | Direct | Jun 11, 2024 (4d) |
| Mar 7, 2024 | JAZZ | ↓ Sell | 3,704 | $118.37 | $438K | Direct | Mar 8, 2024 (1d) |
| Aug 29, 2023 | JAZZ | ↓ Sell | 142 | $143.47 | $20K | Direct | Aug 31, 2023 (2d) |
| Aug 14, 2023 | JAZZ | ↓ Sell | 158 | $138.16 | $22K | Direct | Aug 15, 2023 (1d) |
| Jun 7, 2023 | JAZZ | ↓ Sell | 126 | $127.92 | $16K | Direct | Jun 9, 2023 (2d) |
| Mar 15, 2023 | JAZZ | ↓ Sell | 1,023 | $133.22 | $136K | Direct | Mar 17, 2023 (2d) |
| Mar 5, 2023 | JAZZ | ↓ Sell | 1,148 | $140.76 | $162K | Direct | Mar 7, 2023 (2d) |
| Dec 5, 2022 | JAZZ | ↓ Sell | 63 | $152.06 | $10K | Direct | Dec 7, 2022 (2d) |
| Aug 15, 2022 | JAZZ | ↓ Sell | 2,142 | $160.06 | $343K | Direct | Aug 17, 2022 (2d) |
| Aug 8, 2022 | JAZZ | ↓ Sell | 158 | $152.33 | $24K | Direct | Aug 9, 2022 (1d) |
| Jun 2, 2022 | JAZZ | ↓ Sell | 131 | $150.26 | $20K | Direct | Jun 3, 2022 (1d) |
| May 11, 2022 | JAZZ | ↓ Sell | 2,062 | $147.81 | $305K | Direct | May 11, 2022 (0d) |
| Aug 6, 2021 | JAZZ | ↓ Sell | 157 | $147.96 | $23K | Direct | Aug 10, 2021 (4d) |
| Mar 9, 2021 | JAZZ | ↓ Sell | 2,050 | $161.56 | $331K | Direct | Mar 10, 2021 (1d) |
| Dec 4, 2020 | JAZZ | ↓ Sell | 62 | $152.55 | $9K | Direct | Dec 8, 2020 (4d) |
| Aug 12, 2020 | JAZZ | ↓ Sell | 142 | $123.80 | $18K | Direct | Aug 14, 2020 (2d) |
| Aug 7, 2020 | JAZZ | ↓ Sell | 158 | $125.87 | $20K | Direct | Aug 11, 2020 (4d) |
| Jun 5, 2020 | JAZZ | ↓ Sell | 138 | $124.00 | $17K | Direct | Jun 5, 2020 (0d) |
| Mar 12, 2020 | JAZZ | ↓ Sell | 600 | $102.17 | $61K | Direct | Mar 13, 2020 (1d) |
| Mar 9, 2020 | JAZZ | ↓ Sell | 800 | $113.69 | $91K | Direct | Mar 10, 2020 (1d) |
| Mar 4, 2020 | JAZZ | ↓ Sell | 500 | $119.20 | $60K | Direct | Mar 5, 2020 (1d) |
| Dec 5, 2019 | JAZZ | ↓ Sell | 1,749 | $148.93 | $260K | Direct | Dec 9, 2019 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other JAZZ insiders
Open-market trades in the last 12 months
About Patricia Carr's insider trades
Patricia Carr is SVP, Chief Accounting Officer at Jazz Pharmaceuticals (JAZZ). Since Dec 5, 2019, Patricia has reported no open-market purchases and 30 sales worth $6.2M on SEC Form 4. In the last 12 months: 5 sales ($2.8M).
Their filings also include grants and awards (11 filings), option exercises (6 filings), shares returned to the company (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JAZZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.